UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant To Section 13 OR 15(d) of The Securities Exchange Act of 1934
Pursuant To Section 13 OR 15(d) of The Securities Exchange Act of 1934
|
Date of Report (Date of earliest event reported):
|
|
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
(State or other jurisdiction
of incorporation) |
(Commission File
Number) |
(IRS Employer
Identification No.) |
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
(
|
||
|
(Registrant's telephone number, including area code)
|
||
|
Title of each class
|
Trading Symbol
|
Name of exchange on which registered
|
||
|
|
|
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions.
|
|
|
[
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c)) |
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company [
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
|
This Amendment No. 1 on Form 8-K/A amends the Current Report on Form 8-K filed on March 26, 2024 (the “Original Filing”) by Minerals Technologies Inc. (the
“Company”). The Original Filing reported the election of Dr. Kristina M. Johnson to the Company’s Board of Directors (the “Board”). At the time of the Original Filing, the Board had not made any determinations regarding committee assignments for Dr.
Johnson. The Company hereby amends and supplements the Original Filing to include information on committee assignments and related matters in Item 5.02 below. Other than providing the additional information in Item 5.02 below, no other disclosure in
the Original Filing is amended by this Form 8-K/A.
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On May 14, 2024, the Board appointed Dr. Johnson to the Audit Committee and the Corporate Governance and Nominating Committee of the
Board, having determined that Dr. Johnson satisfies applicable requirements to serve on such Committees.
|
SIGNATURES
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
MINERALS TECHNOLOGIES INC.
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Timothy J. Jordan
|
||
|
|
|
Name:
|
Timothy J. Jordan
|
|
Title:
|
Vice President, General Counsel, Secretary and Chief Compliance Officer
|
||
|
Date: May 16, 2024
|
|
|
|